| Date Filed | Type | Description |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2022 |
4
| Fridriksdottir Hafrun (Executive VP, Global R&D) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Sold 6,116 shares
@ $9.0602, valued at
$55.4k
Exercised 16,121 options to buy
@ $0
Granted 51,488 options to buy
@ $0 |
|
| 08/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2019 |
4
| Fridriksdottir Hafrun (Executive VP, Global R&D) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Sold 4,310 shares
@ $10.4906, valued at
$45.2k
Exercised 8,133 options to buy
@ $0 |
|
| 03/19/2019 |
4
| Fridriksdottir Hafrun (Executive VP, Global R&D) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Sold 263 shares
@ $16.6251, valued at
$4.4k
Sold 93 shares
@ $16.6251, valued at
$1.5k
Exercised 747 options to buy
@ $0
Exercised 265 options to buy
@ $0 |
|
| 03/06/2019 |
4
| Fridriksdottir Hafrun (Executive VP, Global R&D) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Granted 56,716 options to buy
@ $0 |
|
| 03/05/2019 |
4
| Fridriksdottir Hafrun (Executive VP, Global R&D) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Sold 409 shares
@ $16.8833, valued at
$6.9k
Exercised 1,165 options to buy
@ $0 |
|
| 02/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| Fridriksdottir Hafrun (Executive VP, Global R&D) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Sold 1,643 shares
@ $15.7025, valued at
$25.8k
Exercised 4,640 options to buy
@ $0 |
|
| 12/04/2018 |
4
| Fridriksdottir Hafrun (Executive VP, Global R&D) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Sold 933 shares
@ $21.7621, valued at
$20.3k
Exercised 2,711 options to buy
@ $0 |
|
| 03/20/2018 |
4
| Fridriksdottir Hafrun (Executive VP, Global R&D) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Sold 257 shares
@ $17.878, valued at
$4.6k
Sold 91 shares
@ $17.878, valued at
$1.6k
Exercised 747 options to buy
@ $0
Exercised 265 options to buy
@ $0 |
|
| 03/06/2018 |
4
| Fridriksdottir Hafrun (Executive VP, Global R&D) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Paid exercise price by delivering 400 shares
@ $19.38, valued at
$7.8k
Paid exercise price by delivering 1,155 shares
@ $19.38, valued at
$22.4k
Exercised 1,165 options to buy
@ $0
Exercised 3,432 options to buy
@ $0 |
|
| 03/06/2018 |
3/A
| Fridriksdottir Hafrun (Executive VP, Global R&D) has filed a Form 3/A on TEVA PHARMACEUTICAL INDUSTRIES LTD |
| 02/12/2018 |
4
| Fridriksdottir Hafrun (Executive VP, Global R&D) has filed a Form 4 on TEVA PHARMACEUTICAL INDUSTRIES LTD|
Txns:
| Granted 123,288 options to buy
@ $18.61, valued at
$2.3M
Granted 48,361 options to buy
@ $0 |
|
| 01/08/2018 |
3/A
| Fridriksdottir Hafrun (Executive VP, Global R&D) has filed a Form 3/A on TEVA PHARMACEUTICAL INDUSTRIES LTD |
| 01/02/2018 |
3
| Fridriksdottir Hafrun (Executive VP, Global R&D) has filed a Form 3 on TEVA PHARMACEUTICAL INDUSTRIES LTD |
| 05/13/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/03/2013 |
4
| Fridriksdottir Hafrun (SVP, GLOBAL R&D) has filed a Form 4 on Actavis plc|
Txns:
| Granted 5,645 shares
@ $0 |
|
| 10/03/2013 |
3
| Fridriksdottir Hafrun (Sr VP, Global R&D) has filed a Form 3 on Actavis plc |
| 10/02/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|